Evaluating the Effects of Agnikarma Therapy on Knee Osteoarthritis and Inflammation

A Clinical Study to Evaluate the Efficacy of Agnikarma on Knee Osteoarthritis and Pro-inflammatory Biomarkers - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093732

Enrollment

Registered

2025-08-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Grade 2 knee osteoarthritis as per Kellgren and Lawrence classification system

Exclusion criteria

Exclusion criteria: Patients with Rheumatoid arthritis, gouty arthritis, osteomyelitis and septic arthritis of knee joints. Patients with local infection or skin diseases on the proposed site of Agnikarma. Patients suffering from cardiovascular diseases, HIV, hepatitis, diabetes mellitus. Contraindications for Agnikarma9. History of trauma to knee joint. History of surgical intervention on knee joint.

Design outcomes

Primary

Measure	Time frame
Change in symptoms of knee osteoarthritis as per WOMAC scale baseline and after treatmentTimepoint: Change in symptoms of knee osteoarthritis as per WOMAC scale baseline and after treatment	—

Secondary

Measure	Time frame
Change in Pro-inflammatory biomarkers in blood after Agnikarma in knee osteoarthritis baseline & after treatment Identification of type of the Prakriti most vulnerable to Knee Osteoarthritis. Change in the quality of life of the patient Timepoint: Safety	—

Countries

India

Contacts

Public ContactDr Suman Sharma

National Institute of Ayurveda, Deemed to be University

sapnayadav35395@gmail.com8619414716

Outcome results